Author

Maya Singh

Icahn School of Medicine at Mount Sinai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Approach:deep learning· 1

Frequent Co-Authors

Alana Huynh· 1 shared Amber KimiD· 1 shared Amelia EscolanoiD· 1 shared Ami Patel· 1 shared Ashwin N. SkellyiD· 1 shared Beatrice H. HahniD· 1 shared Colby J. AgostinoiD· 1 shared Corey P. MallettiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alana Huynh

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Deep Mining of the Human Antibody Repertoire Identifies Frequent and Genetically Diverse CDRH3 Topologies Targetable by Vaccination

Rumi Habib, Shahlo O. Solieva, Zi Jie Lin, Sukanya Ghosh, Kelly Bayruns, Maya Singh, Colby J. Agostino, Nicholas J. Tursi, Kirsten J. Sowers, Jinwei Huang, Ryan S. Roark, Mansi Purwar, Younghoon Park, Kasirajan Ayyanathan, Hui Li, , Daniel W. Kulp

The paper identifies frequent and genetically diverse CDRH3 topologies in the human antibody repertoire that can be targeted by vaccination to elicit broadly neutralizing antibodies.

Proceedings of the National Academy of Sciences · Apr 29, 2026Peer-reviewedImmunology

Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza virus vaccine adjuvanted with bacterial cell membrane-derived adjuvants

Kirill Vasilev, Irene Hoxie, Eduard Puente‐Massaguer, Joshua Yueh, Disha Bhavsar, Maya Singh, Corey P. Mallett, Joseph Zimmermann, Florian Krammer

This study evaluates an intranasal influenza vaccine based on neuraminidase (NA) adjuvanted with bacterial membrane-derived components, showing improved immunogenicity and protection against H5N1 challenge.

bioRxiv · Feb 26, 2025 · PreprintMicrobiology